Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The disabled dendritic cell.

M Thurnher1, C Zelle-Rieser, R Ramoner

  • 1Department of Urology, University of Innsbruck, A-6020 Innsbruck, Austria. martin.thurnher@uibk.ac.at

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014.

Andrology·2019
Same author

[Unexpected differential diagnosis of urachal cancer].

Der Urologe. Ausg. A·2018
Same author

[Urolithiasis 2016 : Reliable, effective and low radiation exposure].

Der Urologe. Ausg. A·2016
Same author

Good news about the ESNR-Springer Award.

Neuroradiology·2016
Same author

[Patient blood management: Current state of the literature].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2015
Same author

How to image patients with spine pain.

European journal of radiology·2014

Monocyte-derived dendritic cells have impaired functions due to a deficiency in platelet-activating factor and eicosanoid production. This biochemical defect limits their ability to enhance antitumor immunity in cancer patients.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Dendritic cells are crucial antigen-presenting cells that regulate immune responses.
  • In vitro generated monocyte-derived dendritic cells (moDCs) are used in cancer immunotherapy.
  • Recent findings suggest moDCs have functional deficits compared to other dendritic cells.

Purpose of the Study:

  • To investigate the biochemical basis for functional deficiencies in moDCs.
  • To identify a potential single molecular defect responsible for impaired moDC functions.

Main Methods:

  • Analysis of cytokine-induced dendritic cell generation.
  • Biochemical assays to measure enzyme activity and molecular production.
  • Comparison of moDC functions with other dendritic cell types.

Related Experiment Videos

Main Results:

  • Interleukin-4 (IL-4), used in moDC generation, suppresses phospholipase A2 activity.
  • This suppression leads to deficient production of platelet-activating factor and eicosanoids (prostaglandins, leukotrienes, lipoxins) in moDCs.
  • Impaired biosynthesis of these molecules correlates with deficits in moDC migration, natural killer cell activation, and T helper cell differentiation.

Conclusions:

  • A deficiency in platelet-activating factor and eicosanoid biosynthesis is proposed as the cause of functional impairments in moDCs.
  • This biochemical defect may limit the clinical efficacy of moDCs in enhancing antitumor immunity.
  • Further research into restoring these pathways could improve moDC-based cancer therapies.